Literature DB >> 17565011

Who is (still) getting HIT?

Theodore E Warkentin, John W Eikelboom.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565011     DOI: 10.1378/chest.07-0425

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  6 in total

Review 1.  Prevention of venous thromboembolism in gynecologic oncology surgery.

Authors:  Emma L Barber; Daniel L Clarke-Pearson
Journal:  Gynecol Oncol       Date:  2016-11-25       Impact factor: 5.482

Review 2.  Antiplatelet medications and evolving antithrombotic medication.

Authors:  Jonathan Ryan; Ferdia Bolster; Ian Crosbie; Eoin Kavanagh
Journal:  Skeletal Radiol       Date:  2013-01-19       Impact factor: 2.199

3.  Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.

Authors:  Miao Wang; Andrew E Moran; Jing Liu; Pamela G Coxson; Paul A Heidenreich; Dongfeng Gu; Jiang He; Lee Goldman; Dong Zhao
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2014-01-14

4.  Hereditary and acquired thrombophilic disorders complicating vascular access in haemodialysis: O. Sarkar et al.

Authors:  Oliver Sarkar; Afshin Assadian; Helga Frank; Georg Moessmer; Uwe Heemann; Hans-Henning Eckstein
Journal:  NDT Plus       Date:  2010-04-13

5.  Heparin-induced thrombocytopaenia (HIT)-an overview: what does the nephrologist need to know and do?

Authors:  Tina Dutt; Michael Schulz
Journal:  Clin Kidney J       Date:  2013-12

6.  Measurement of procoagulant platelets provides mechanistic insight and diagnostic potential in heparin-induced thrombocytopenia.

Authors:  Christine S M Lee; Maria V Selvadurai; Leonardo Pasalic; James Yeung; Maria Konda; Geoffrey W Kershaw; Emmanuel J Favaloro; Vivien M Chen
Journal:  J Thromb Haemost       Date:  2022-02-07       Impact factor: 16.036

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.